Premier Laser Systems
This article was originally published in The Gray Sheet
Executive Summary
Names Haskell & White LLP as independent auditor June 23. The firm's former auditor, Ernst & Young, resigned May 22 over concerns related to the "limited scope and breadth" of Premier's investigation of accounting discrepancies ("The Gray Sheet" June 8, p. 19). Premier has completed its response to a June NASDAQ inquiry which resulted in the suspension of its stock from trading, the company notes. Audited financial reports will be submitted to NASDAQ "as soon as they are available," Premier maintains...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.